Evolving Landscape for Frontline Treatment in Clear Cell Metastatic Renal Cell Carcinoma

SCCA’s Petros Grivas, MD, PhD, reviewed the evolving landscape of metastatic renal cell carcinoma,  highlighting the trial design and the recently published CLEAR study.

Watch the UroToday Video